APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pemetrexed Disodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium for Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium for Injection Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium for Injection Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium for Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pemetrexed Disodium for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pemetrexed Disodium for Injection include Accord Healthcare, Amneal Pharmaceuticals, APOTEX, Biocon, Dr. Reddy's Laboratories, Eugia Pharma, Nang Kuang Pharmaceutical, Pfizer (Hospira) and Waverley Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pemetrexed Disodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pemetrexed Disodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pemetrexed Disodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pemetrexed Disodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Pemetrexed Disodium for Injection Segment by Company

Accord Healthcare

Amneal Pharmaceuticals

APOTEX

Biocon

Dr. Reddy's Laboratories

Eugia Pharma

Nang Kuang Pharmaceutical

Pfizer (Hospira)

Waverley Pharma

Zydus Lifesciences

Baxter

Beijing Xiehe Pharmaceutical

Dezhou Deyao Pharmaceutical

Fresenius Kabi

Hainan Jinrui Pharmaceutical

Kelun Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Lilly

Lianyungang Jaripharm Pharmaceutical

Nanjing Pharmaceutical Factory

Jiangsu Hansoh Pharmaceutical

Sandoz

Zhendong Group

Shanghai Chemo Wanbang Biopharma

Sichuan Huiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Suzhou Thery Pharmaceutical

Jiangsu Simcere Pharmaceutical

Yangtze River Pharmaceutical Group

Pemetrexed Disodium for Injection Segment by Type

500mg/Pcs

100mg/Pcs

Pemetrexed Disodium for Injection Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pemetrexed Disodium for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pemetrexed Disodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pemetrexed Disodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pemetrexed Disodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pemetrexed Disodium for Injection Industry Trends Table 2. Pemetrexed Disodium for Injection Industry Drivers Table 3. Pemetrexed Disodium for Injection Industry Opportunities and Challenges Table 4. Pemetrexed Disodium for Injection Industry Restraints Table 5. Global Pemetrexed Disodium for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pemetrexed Disodium for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pemetrexed Disodium for Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers Table 9. Global Pemetrexed Disodium for Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pemetrexed Disodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pemetrexed Disodium for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pemetrexed Disodium for Injection Manufacturers, Product Type & Application Table 13. Global Pemetrexed Disodium for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pemetrexed Disodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500mg/Pcs Table 17. Major Manufacturers of 100mg/Pcs Table 18. Global Pemetrexed Disodium for Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 20. Global Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 21. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2026) Table 22. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2027-2032) Table 23. Global Pemetrexed Disodium for Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (k units) Table 25. Global Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (k units) Table 26. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Pemetrexed Disodium for Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 33. Global Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 34. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2026) Table 35. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2027-2032) Table 36. Global Pemetrexed Disodium for Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (k units) Table 38. Global Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (k units) Table 39. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2026) Table 40. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2027-2032) Table 41. Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (k units) Table 43. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2026) Table 44. Global Pemetrexed Disodium for Injection Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Pemetrexed Disodium for Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 48. North America Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 49. Europe Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 51. Europe Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 58. Global Pemetrexed Disodium for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pemetrexed Disodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pemetrexed Disodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2026) Table 62. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2027-2032) Table 63. Accord Healthcare Company Information Table 64. Accord Healthcare Business Overview Table 65. Accord Healthcare Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio Table 67. Accord Healthcare Recent Development Table 68. Amneal Pharmaceuticals Company Information Table 69. Amneal Pharmaceuticals Business Overview Table 70. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio Table 72. Amneal Pharmaceuticals Recent Development Table 73. APOTEX Company Information Table 74. APOTEX Business Overview Table 75. APOTEX Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. APOTEX Pemetrexed Disodium for Injection Product Portfolio Table 77. APOTEX Recent Development Table 78. Biocon Company Information Table 79. Biocon Business Overview Table 80. Biocon Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biocon Pemetrexed Disodium for Injection Product Portfolio Table 82. Biocon Recent Development Table 83. Dr. Reddy's Laboratories Company Information Table 84. Dr. Reddy's Laboratories Business Overview Table 85. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio Table 87. Dr. Reddy's Laboratories Recent Development Table 88. Eugia Pharma Company Information Table 89. Eugia Pharma Business Overview Table 90. Eugia Pharma Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio Table 92. Eugia Pharma Recent Development Table 93. Nang Kuang Pharmaceutical Company Information Table 94. Nang Kuang Pharmaceutical Business Overview Table 95. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 97. Nang Kuang Pharmaceutical Recent Development Table 98. Pfizer (Hospira) Company Information Table 99. Pfizer (Hospira) Business Overview Table 100. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio Table 102. Pfizer (Hospira) Recent Development Table 103. Waverley Pharma Company Information Table 104. Waverley Pharma Business Overview Table 105. Waverley Pharma Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio Table 107. Waverley Pharma Recent Development Table 108. Zydus Lifesciences Company Information Table 109. Zydus Lifesciences Business Overview Table 110. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio Table 112. Zydus Lifesciences Recent Development Table 113. Baxter Company Information Table 114. Baxter Business Overview Table 115. Baxter Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Baxter Pemetrexed Disodium for Injection Product Portfolio Table 117. Baxter Recent Development Table 118. Beijing Xiehe Pharmaceutical Company Information Table 119. Beijing Xiehe Pharmaceutical Business Overview Table 120. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 122. Beijing Xiehe Pharmaceutical Recent Development Table 123. Dezhou Deyao Pharmaceutical Company Information Table 124. Dezhou Deyao Pharmaceutical Business Overview Table 125. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 127. Dezhou Deyao Pharmaceutical Recent Development Table 128. Fresenius Kabi Company Information Table 129. Fresenius Kabi Business Overview Table 130. Fresenius Kabi Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio Table 132. Fresenius Kabi Recent Development Table 133. Hainan Jinrui Pharmaceutical Company Information Table 134. Hainan Jinrui Pharmaceutical Business Overview Table 135. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 137. Hainan Jinrui Pharmaceutical Recent Development Table 138. Kelun Pharmaceutical Company Information Table 139. Kelun Pharmaceutical Business Overview Table 140. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 142. Kelun Pharmaceutical Recent Development Table 143. Jiangsu Aosaikang Pharmaceutical Company Information Table 144. Jiangsu Aosaikang Pharmaceutical Business Overview Table 145. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 147. Jiangsu Aosaikang Pharmaceutical Recent Development Table 148. Qilu Pharmaceutical Company Information Table 149. Qilu Pharmaceutical Business Overview Table 150. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 152. Qilu Pharmaceutical Recent Development Table 153. Lilly Company Information Table 154. Lilly Business Overview Table 155. Lilly Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Lilly Pemetrexed Disodium for Injection Product Portfolio Table 157. Lilly Recent Development Table 158. Lianyungang Jaripharm Pharmaceutical Company Information Table 159. Lianyungang Jaripharm Pharmaceutical Business Overview Table 160. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 162. Lianyungang Jaripharm Pharmaceutical Recent Development Table 163. Nanjing Pharmaceutical Factory Company Information Table 164. Nanjing Pharmaceutical Factory Business Overview Table 165. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio Table 167. Nanjing Pharmaceutical Factory Recent Development Table 168. Jiangsu Hansoh Pharmaceutical Company Information Table 169. Jiangsu Hansoh Pharmaceutical Business Overview Table 170. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 172. Jiangsu Hansoh Pharmaceutical Recent Development Table 173. Sandoz Company Information Table 174. Sandoz Business Overview Table 175. Sandoz Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Sandoz Pemetrexed Disodium for Injection Product Portfolio Table 177. Sandoz Recent Development Table 178. Zhendong Group Company Information Table 179. Zhendong Group Business Overview Table 180. Zhendong Group Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Zhendong Group Pemetrexed Disodium for Injection Product Portfolio Table 182. Zhendong Group Recent Development Table 183. Shanghai Chemo Wanbang Biopharma Company Information Table 184. Shanghai Chemo Wanbang Biopharma Business Overview Table 185. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 186. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio Table 187. Shanghai Chemo Wanbang Biopharma Recent Development Table 188. Sichuan Huiyu Pharmaceutical Company Information Table 189. Sichuan Huiyu Pharmaceutical Business Overview Table 190. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 191. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 192. Sichuan Huiyu Pharmaceutical Recent Development Table 193. Suzhou Erye Pharmaceutical Company Information Table 194. Suzhou Erye Pharmaceutical Business Overview Table 195. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 196. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 197. Suzhou Erye Pharmaceutical Recent Development Table 198. Suzhou Thery Pharmaceutical Company Information Table 199. Suzhou Thery Pharmaceutical Business Overview Table 200. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 201. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 202. Suzhou Thery Pharmaceutical Recent Development Table 203. Jiangsu Simcere Pharmaceutical Company Information Table 204. Jiangsu Simcere Pharmaceutical Business Overview Table 205. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 206. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 207. Jiangsu Simcere Pharmaceutical Recent Development Table 208. Yangtze River Pharmaceutical Group Company Information Table 209. Yangtze River Pharmaceutical Group Business Overview Table 210. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 211. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio Table 212. Yangtze River Pharmaceutical Group Recent Development Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Pemetrexed Disodium for Injection Distributors List Table 216. Pemetrexed Disodium for Injection Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Pemetrexed Disodium for Injection Product Image Figure 2. Global Pemetrexed Disodium for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Disodium for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Disodium for Injection Sales (2021-2032) & (k units) Figure 5. Global Pemetrexed Disodium for Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pemetrexed Disodium for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500mg/Pcs Image Figure 9. 100mg/Pcs Image Figure 10. Global Pemetrexed Disodium for Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pemetrexed Disodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Pemetrexed Disodium for Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pemetrexed Disodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Pemetrexed Disodium for Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pemetrexed Disodium for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2032) Figure 22. Global Pemetrexed Disodium for Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pemetrexed Disodium for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032) Figure 39. China Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pemetrexed Disodium for Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Pemetrexed Disodium for Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Pemetrexed Disodium for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pemetrexed Disodium for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pemetrexed Disodium for Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pemetrexed Disodium for Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg/Pcs
  • 100mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Accord Healthcare
  • Amneal Pharmaceuticals
  • APOTEX
  • Biocon
  • Dr. Reddy's Laboratories
  • Eugia Pharma
  • Nang Kuang Pharmaceutical
  • Pfizer (Hospira)
  • Waverley Pharma
  • Zydus Lifesciences
  • Baxter
  • Beijing Xiehe Pharmaceutical
  • Dezhou Deyao Pharmaceutical
  • Fresenius Kabi
  • Hainan Jinrui Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Lilly
  • Lianyungang Jaripharm Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Jiangsu Hansoh Pharmaceutical
  • Sandoz
  • Zhendong Group
  • Shanghai Chemo Wanbang Biopharma
  • Sichuan Huiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Jiangsu Simcere Pharmaceutical
  • Yangtze River Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pemetrexed Disodium for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pemetrexed Disodium for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pemetrexed Disodium for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pemetrexed Disodium for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pemetrexed Disodium for Injection Market Dynamics
  1. 2.1 Pemetrexed Disodium for Injection Industry Trends
  2. 2.2 Pemetrexed Disodium for Injection Industry Drivers
  3. 2.3 Pemetrexed Disodium for Injection Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Disodium for Injection Industry Restraints
3 Pemetrexed Disodium for Injection Market by Manufacturers
  1. 3.1 Global Pemetrexed Disodium for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pemetrexed Disodium for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pemetrexed Disodium for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pemetrexed Disodium for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pemetrexed Disodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pemetrexed Disodium for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Pemetrexed Disodium for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pemetrexed Disodium for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pemetrexed Disodium for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pemetrexed Disodium for Injection Tier 1, Tier 2, and Tier 3
4 Pemetrexed Disodium for Injection Market by Type
  1. 4.1 Pemetrexed Disodium for Injection Type Introduction
  2. 4.1.1 500mg/Pcs
  3. 4.1.2 100mg/Pcs
  4. 4.2 Global Pemetrexed Disodium for Injection Sales by Type
  5. 4.2.1 Global Pemetrexed Disodium for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pemetrexed Disodium for Injection Revenue by Type
  9. 4.3.1 Global Pemetrexed Disodium for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2032)
5 Pemetrexed Disodium for Injection Market by Application
  1. 5.1 Pemetrexed Disodium for Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Disodium for Injection Sales by Application
  6. 5.2.1 Global Pemetrexed Disodium for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pemetrexed Disodium for Injection Revenue by Application
  10. 5.3.1 Global Pemetrexed Disodium for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2032)
6 Global Pemetrexed Disodium for Injection Sales by Region
  1. 6.1 Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pemetrexed Disodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Pemetrexed Disodium for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Pemetrexed Disodium for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pemetrexed Disodium for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pemetrexed Disodium for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pemetrexed Disodium for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pemetrexed Disodium for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pemetrexed Disodium for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pemetrexed Disodium for Injection Revenue by Region
  1. 7.1 Global Pemetrexed Disodium for Injection Revenue by Region
  2. 7.1.1 Global Pemetrexed Disodium for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pemetrexed Disodium for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Pemetrexed Disodium for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pemetrexed Disodium for Injection Revenue (2021-2032)
  8. 7.2.2 North America Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pemetrexed Disodium for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pemetrexed Disodium for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pemetrexed Disodium for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pemetrexed Disodium for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 APOTEX
  14. 8.3.1 APOTEX Company Information
  15. 8.3.2 APOTEX Business Overview
  16. 8.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
  18. 8.3.5 APOTEX Recent Developments
  19. 8.4 Biocon
  20. 8.4.1 Biocon Company Information
  21. 8.4.2 Biocon Business Overview
  22. 8.4.3 Biocon Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
  24. 8.4.5 Biocon Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Eugia Pharma
  32. 8.6.1 Eugia Pharma Company Information
  33. 8.6.2 Eugia Pharma Business Overview
  34. 8.6.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
  36. 8.6.5 Eugia Pharma Recent Developments
  37. 8.7 Nang Kuang Pharmaceutical
  38. 8.7.1 Nang Kuang Pharmaceutical Company Information
  39. 8.7.2 Nang Kuang Pharmaceutical Business Overview
  40. 8.7.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  42. 8.7.5 Nang Kuang Pharmaceutical Recent Developments
  43. 8.8 Pfizer (Hospira)
  44. 8.8.1 Pfizer (Hospira) Company Information
  45. 8.8.2 Pfizer (Hospira) Business Overview
  46. 8.8.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
  48. 8.8.5 Pfizer (Hospira) Recent Developments
  49. 8.9 Waverley Pharma
  50. 8.9.1 Waverley Pharma Company Information
  51. 8.9.2 Waverley Pharma Business Overview
  52. 8.9.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
  54. 8.9.5 Waverley Pharma Recent Developments
  55. 8.10 Zydus Lifesciences
  56. 8.10.1 Zydus Lifesciences Company Information
  57. 8.10.2 Zydus Lifesciences Business Overview
  58. 8.10.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
  60. 8.10.5 Zydus Lifesciences Recent Developments
  61. 8.11 Baxter
  62. 8.11.1 Baxter Company Information
  63. 8.11.2 Baxter Business Overview
  64. 8.11.3 Baxter Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
  66. 8.11.5 Baxter Recent Developments
  67. 8.12 Beijing Xiehe Pharmaceutical
  68. 8.12.1 Beijing Xiehe Pharmaceutical Company Information
  69. 8.12.2 Beijing Xiehe Pharmaceutical Business Overview
  70. 8.12.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  72. 8.12.5 Beijing Xiehe Pharmaceutical Recent Developments
  73. 8.13 Dezhou Deyao Pharmaceutical
  74. 8.13.1 Dezhou Deyao Pharmaceutical Company Information
  75. 8.13.2 Dezhou Deyao Pharmaceutical Business Overview
  76. 8.13.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  78. 8.13.5 Dezhou Deyao Pharmaceutical Recent Developments
  79. 8.14 Fresenius Kabi
  80. 8.14.1 Fresenius Kabi Company Information
  81. 8.14.2 Fresenius Kabi Business Overview
  82. 8.14.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
  84. 8.14.5 Fresenius Kabi Recent Developments
  85. 8.15 Hainan Jinrui Pharmaceutical
  86. 8.15.1 Hainan Jinrui Pharmaceutical Company Information
  87. 8.15.2 Hainan Jinrui Pharmaceutical Business Overview
  88. 8.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  90. 8.15.5 Hainan Jinrui Pharmaceutical Recent Developments
  91. 8.16 Kelun Pharmaceutical
  92. 8.16.1 Kelun Pharmaceutical Company Information
  93. 8.16.2 Kelun Pharmaceutical Business Overview
  94. 8.16.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  96. 8.16.5 Kelun Pharmaceutical Recent Developments
  97. 8.17 Jiangsu Aosaikang Pharmaceutical
  98. 8.17.1 Jiangsu Aosaikang Pharmaceutical Company Information
  99. 8.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  100. 8.17.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  102. 8.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  103. 8.18 Qilu Pharmaceutical
  104. 8.18.1 Qilu Pharmaceutical Company Information
  105. 8.18.2 Qilu Pharmaceutical Business Overview
  106. 8.18.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  108. 8.18.5 Qilu Pharmaceutical Recent Developments
  109. 8.19 Lilly
  110. 8.19.1 Lilly Company Information
  111. 8.19.2 Lilly Business Overview
  112. 8.19.3 Lilly Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
  114. 8.19.5 Lilly Recent Developments
  115. 8.20 Lianyungang Jaripharm Pharmaceutical
  116. 8.20.1 Lianyungang Jaripharm Pharmaceutical Company Information
  117. 8.20.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  118. 8.20.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  120. 8.20.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  121. 8.21 Nanjing Pharmaceutical Factory
  122. 8.21.1 Nanjing Pharmaceutical Factory Company Information
  123. 8.21.2 Nanjing Pharmaceutical Factory Business Overview
  124. 8.21.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
  126. 8.21.5 Nanjing Pharmaceutical Factory Recent Developments
  127. 8.22 Jiangsu Hansoh Pharmaceutical
  128. 8.22.1 Jiangsu Hansoh Pharmaceutical Company Information
  129. 8.22.2 Jiangsu Hansoh Pharmaceutical Business Overview
  130. 8.22.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  132. 8.22.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  133. 8.23 Sandoz
  134. 8.23.1 Sandoz Company Information
  135. 8.23.2 Sandoz Business Overview
  136. 8.23.3 Sandoz Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
  138. 8.23.5 Sandoz Recent Developments
  139. 8.24 Zhendong Group
  140. 8.24.1 Zhendong Group Company Information
  141. 8.24.2 Zhendong Group Business Overview
  142. 8.24.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
  144. 8.24.5 Zhendong Group Recent Developments
  145. 8.25 Shanghai Chemo Wanbang Biopharma
  146. 8.25.1 Shanghai Chemo Wanbang Biopharma Company Information
  147. 8.25.2 Shanghai Chemo Wanbang Biopharma Business Overview
  148. 8.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
  150. 8.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  151. 8.26 Sichuan Huiyu Pharmaceutical
  152. 8.26.1 Sichuan Huiyu Pharmaceutical Company Information
  153. 8.26.2 Sichuan Huiyu Pharmaceutical Business Overview
  154. 8.26.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  156. 8.26.5 Sichuan Huiyu Pharmaceutical Recent Developments
  157. 8.27 Suzhou Erye Pharmaceutical
  158. 8.27.1 Suzhou Erye Pharmaceutical Company Information
  159. 8.27.2 Suzhou Erye Pharmaceutical Business Overview
  160. 8.27.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  162. 8.27.5 Suzhou Erye Pharmaceutical Recent Developments
  163. 8.28 Suzhou Thery Pharmaceutical
  164. 8.28.1 Suzhou Thery Pharmaceutical Company Information
  165. 8.28.2 Suzhou Thery Pharmaceutical Business Overview
  166. 8.28.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  168. 8.28.5 Suzhou Thery Pharmaceutical Recent Developments
  169. 8.29 Jiangsu Simcere Pharmaceutical
  170. 8.29.1 Jiangsu Simcere Pharmaceutical Company Information
  171. 8.29.2 Jiangsu Simcere Pharmaceutical Business Overview
  172. 8.29.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  174. 8.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
  175. 8.30 Yangtze River Pharmaceutical Group
  176. 8.30.1 Yangtze River Pharmaceutical Group Company Information
  177. 8.30.2 Yangtze River Pharmaceutical Group Business Overview
  178. 8.30.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
  180. 8.30.5 Yangtze River Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pemetrexed Disodium for Injection Value Chain Analysis
  2. 9.1.1 Pemetrexed Disodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pemetrexed Disodium for Injection Production Mode & Process
  6. 9.2 Pemetrexed Disodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pemetrexed Disodium for Injection Distributors
  9. 9.2.3 Pemetrexed Disodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst